Navigation

P2

Poster
Association of Hyperhomocysteinemia with Acute Myocardial Infarction in Iraqi Patients

S. Othman Amen1, S. Tharwat Baban2 (1Rostock DE; 2Nottingham GB)


Background: Coronary Artery Disease(CAD), and its major manifestation, Acute Myocardial Infarction(AMI) are the most common causes of death worldwide. Hyperhomocysteinemia(HHcy) has been recently recognised as a new emerging cardiovascular risk factor mediating in development of CAD risk.HHcy causes endothelial dysfunction, resulting in local thrombosis and subsequent ischemia. However, the role of HHcy in increasing risk of CAD still remains controversial and elusive.

Aim: The major aim of this study is to determine the association between HHcy with increased risk of CAD in patients with AMI in Kurdish population.  Its role in development of CAD could be pivotal. 

Design and method: In this case-control study, a total of 74 patients with AMI and 74 age and gender-matched individuals as control group were enrolled.The serum tHcy level was measured by enzymatic immunoassay.HHcy was defined as Hcy>15µmol/l.

Results: The prevalence of HHcy was significantly higher in AMI patients (68.9%) than in control group (29.7%) (P<0.0001).The mean serum tHcy level was higher in AMI patients than that in control group (22.8µmol/l and 15.1µmol/l, respectively, P<0.0001).Moreover, the mean tHcy level for the male patients were about 7 μmol/L greater than those for the female patients. 

Conclusion: HHcy is strongly associated with increased risk of CAD independent of conventional risk factors such as hyperlipidemia, Diabetes, hypertension, smoking and family history of premature CAD factors. This study concludes that HHcy is a new independent cardiovascular risk factor of CAD and AMI. 

    
        Array
(
    [id] => 12
    [abstract_id] => 17
    [session_id] => 1
    [pres_nbr] => P2
    [updated] => 
    [created] => 0000-00-00 00:00:00
    [abstract] => Array
        (
            [id] => 17
            [user_id] => 11
            [contact_id] => 11
            [knr] => 23737461
            [titel] => Association of Hyperhomocysteinemia with Acute Myocardial Infarction in Iraqi Patients

            [text] => 

Background: Coronary Artery Disease(CAD), and its major manifestation, Acute Myocardial Infarction(AMI) are the most common causes of death worldwide. Hyperhomocysteinemia(HHcy) has been recently recognised as a new emerging cardiovascular risk factor mediating in development of CAD risk.HHcy causes endothelial dysfunction, resulting in local thrombosis and subsequent ischemia. However, the role of HHcy in increasing risk of CAD still remains controversial and elusive.

Aim: The major aim of this study is to determine the association between HHcy with increased risk of CAD in patients with AMI in Kurdish population.  Its role in development of CAD could be pivotal. 

Design and method: In this case-control study, a total of 74 patients with AMI and 74 age and gender-matched individuals as control group were enrolled.The serum tHcy level was measured by enzymatic immunoassay.HHcy was defined as Hcy>15µmol/l.

Results: The prevalence of HHcy was significantly higher in AMI patients (68.9%) than in control group (29.7%) (P<0.0001).The mean serum tHcy level was higher in AMI patients than that in control group (22.8µmol/l and 15.1µmol/l, respectively, P<0.0001).Moreover, the mean tHcy level for the male patients were about 7 μmol/L greater than those for the female patients. 

Conclusion: HHcy is strongly associated with increased risk of CAD independent of conventional risk factors such as hyperlipidemia, Diabetes, hypertension, smoking and family history of premature CAD factors. This study concludes that HHcy is a new independent cardiovascular risk factor of CAD and AMI. 

[pres_form] => [bio_presenting_author] => [german_presentation] => 0 [contact_complete] => 1 [authors_complete] => 1 [abstract_complete] => 1 [images_complete] => 1 [confirmation_complete] => 1 [updated] => [created] => 2019-01-01 18:12:34 [sprache] => en [atherosclerosis_basic] => 1 [atherosclerosis_clinical] => 1 [heartfailure_basic] => 1 [heartfailure_clinical] => 1 [arrhythmia_basic] => 0 [arrhythmia_clinical] => 0 [hypertension_diabetes_dyslipidemia] => 1 [preventive_medicine] => 0 [contact] => stdClass Object ( [id] => 11 [user_id] => 11 [anrede] => 3 [akad_titel] => 1 [vorname] => Soza [name] => Baban [institution] => The University of Nottingham [department] => [adresszeile1] => The University of Nottingham, Nottingham, UK [adresszeile2] => [adresszeile3] => [plz] => Biomolecular sc [ort] => Nottingham [land] => GB [email] => sozy.baban@gmail.com [telefon] => [lang] => [updated] => [created] => 0000-00-00 00:00:00 ) [authors] => Array ( [0] => stdClass Object ( [id] => 16 [abstract_id] => 17 [vorname] => Shwan [name] => Othman Amen [qualification] => [institution] => Rostock Medical University, cardiology Department,Germany. [ort] => Rostock [land] => DE [sort] => 1 [is_presenting_author] => [updated] => [created] => 0000-00-00 00:00:00 ) [1] => stdClass Object ( [id] => 17 [abstract_id] => 17 [vorname] => Soza [name] => Tharwat Baban [qualification] => [institution] => The University of Nottingham [ort] => Nottingham [land] => GB [sort] => 2 [is_presenting_author] => [updated] => [created] => 0000-00-00 00:00:00 ) ) [files] => Array ( ) [main_author] => stdClass Object ( [id] => 16 [abstract_id] => 17 [vorname] => Shwan [name] => Othman Amen [qualification] => [institution] => Rostock Medical University, cardiology Department,Germany. [ort] => Rostock [land] => DE [sort] => 1 [is_presenting_author] => [updated] => [created] => 0000-00-00 00:00:00 ) [formatted_contact] =>
Soza Baban
GB-Biomolecular sc Nottingham
sozy.baban@gmail.com ) [session] => stdClass Object ( [id] => 1 [name] => Poster [date] => 2019-05-09 [start] => 00:00:00 [end] => 00:00:00 [abbr] => P [updated] => [created] => 0000-00-00 00:00:00 ) [formatted_authors] => S. Othman Amen1, S. Tharwat Baban2 (1Rostock DE; 2Nottingham GB) [detail_url] => https://www.iscp2019.com/abstracts/presentation/12 )